nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCC2—esophageal cancer	0.223	0.731	CbGaD
Conjugated Estrogens—ABCC11—Methotrexate—esophageal cancer	0.0919	0.187	CbGbCtD
Conjugated Estrogens—ABCB1—esophageal cancer	0.082	0.269	CbGaD
Conjugated Estrogens—SLCO3A1—Methotrexate—esophageal cancer	0.0631	0.129	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—esophageal cancer	0.0403	0.0822	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—esophageal cancer	0.0391	0.0796	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—esophageal cancer	0.0254	0.0517	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—esophageal cancer	0.0225	0.0459	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—esophageal cancer	0.0208	0.0424	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—esophageal cancer	0.0208	0.0424	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—esophageal cancer	0.0194	0.0395	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—esophageal cancer	0.0188	0.0383	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—esophageal cancer	0.0178	0.0362	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—esophageal cancer	0.0161	0.0327	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—esophageal cancer	0.0156	0.0317	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—esophageal cancer	0.0139	0.0283	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—esophageal cancer	0.0131	0.0267	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—esophageal cancer	0.0121	0.0247	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—esophageal cancer	0.0115	0.0235	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—esophageal cancer	0.0104	0.0212	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—esophageal cancer	0.00843	0.0172	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—esophageal cancer	0.00579	0.0118	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—esophageal cancer	0.00376	0.00766	CbGbCtD
Conjugated Estrogens—SLC51B—digestive system—esophageal cancer	0.00164	0.0492	CbGeAlD
Conjugated Estrogens—SLC51A—bronchus—esophageal cancer	0.00152	0.0456	CbGeAlD
Conjugated Estrogens—SLC51B—lung—esophageal cancer	0.00137	0.0411	CbGeAlD
Conjugated Estrogens—SLC51A—trachea—esophageal cancer	0.00137	0.041	CbGeAlD
Conjugated Estrogens—SLC51A—digestive system—esophageal cancer	0.00118	0.0353	CbGeAlD
Conjugated Estrogens—ESR2—neck—esophageal cancer	0.000984	0.0295	CbGeAlD
Conjugated Estrogens—SLC51A—lung—esophageal cancer	0.000983	0.0295	CbGeAlD
Conjugated Estrogens—SLCO3A1—bronchus—esophageal cancer	0.000816	0.0245	CbGeAlD
Conjugated Estrogens—SLC10A1—digestive system—esophageal cancer	0.000763	0.0229	CbGeAlD
Conjugated Estrogens—SLCO4A1—bronchus—esophageal cancer	0.000744	0.0223	CbGeAlD
Conjugated Estrogens—SLCO1B3—lung—esophageal cancer	0.00073	0.0219	CbGeAlD
Conjugated Estrogens—SLC22A11—digestive system—esophageal cancer	0.000696	0.0209	CbGeAlD
Conjugated Estrogens—ESR1—neck—esophageal cancer	0.000674	0.0202	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—esophageal cancer	0.000672	0.0201	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—esophageal cancer	0.00067	0.0201	CbGeAlD
Conjugated Estrogens—SLCO4A1—trachea—esophageal cancer	0.000668	0.02	CbGeAlD
Conjugated Estrogens—ESR2—smooth muscle tissue—esophageal cancer	0.000645	0.0193	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—NR1I2—esophageal cancer	0.000631	0.201	CrCbGaD
Conjugated Estrogens—COMT—bronchus—esophageal cancer	0.000629	0.0188	CbGeAlD
Conjugated Estrogens—Exemestane—CYP19A1—esophageal cancer	0.000626	0.199	CrCbGaD
Conjugated Estrogens—COMT—smooth muscle tissue—esophageal cancer	0.000615	0.0184	CbGeAlD
Conjugated Estrogens—SLCO4A1—digestive system—esophageal cancer	0.000575	0.0172	CbGeAlD
Conjugated Estrogens—COMT—trachea—esophageal cancer	0.000565	0.0169	CbGeAlD
Conjugated Estrogens—SLCO3A1—lung—esophageal cancer	0.000527	0.0158	CbGeAlD
Conjugated Estrogens—ABCC4—bronchus—esophageal cancer	0.000513	0.0154	CbGeAlD
Conjugated Estrogens—ESR2—digestive system—esophageal cancer	0.00051	0.0153	CbGeAlD
Conjugated Estrogens—SLCO1B1—digestive system—esophageal cancer	0.000506	0.0152	CbGeAlD
Conjugated Estrogens—COMT—digestive system—esophageal cancer	0.000486	0.0146	CbGeAlD
Conjugated Estrogens—SLCO4A1—lung—esophageal cancer	0.00048	0.0144	CbGeAlD
Conjugated Estrogens—ABCC3—digestive system—esophageal cancer	0.00048	0.0144	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—esophageal cancer	0.000459	0.0137	CbGeAlD
Conjugated Estrogens—SLCO2B1—digestive system—esophageal cancer	0.000447	0.0134	CbGeAlD
Conjugated Estrogens—ESR1—smooth muscle tissue—esophageal cancer	0.000442	0.0132	CbGeAlD
Conjugated Estrogens—ABCC1—bronchus—esophageal cancer	0.000437	0.0131	CbGeAlD
Conjugated Estrogens—ESR2—lung—esophageal cancer	0.000426	0.0128	CbGeAlD
Conjugated Estrogens—Estradiol—NR1I2—esophageal cancer	0.000417	0.133	CrCbGaD
Conjugated Estrogens—SLCO1A2—digestive system—esophageal cancer	0.000411	0.0123	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—esophageal cancer	0.00041	0.0123	CbGeAlD
Conjugated Estrogens—COMT—lung—esophageal cancer	0.000406	0.0122	CbGeAlD
Conjugated Estrogens—ABCC3—lung—esophageal cancer	0.000401	0.012	CbGeAlD
Conjugated Estrogens—ABCC4—digestive system—esophageal cancer	0.000396	0.0119	CbGeAlD
Conjugated Estrogens—ABCC1—trachea—esophageal cancer	0.000392	0.0118	CbGeAlD
Conjugated Estrogens—ABCC2—digestive system—esophageal cancer	0.000383	0.0115	CbGeAlD
Conjugated Estrogens—SLCO2B1—lung—esophageal cancer	0.000373	0.0112	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—esophageal cancer	0.00036	0.0108	CbGeAlD
Conjugated Estrogens—ESR1—digestive system—esophageal cancer	0.000349	0.0105	CbGeAlD
Conjugated Estrogens—SLCO1A2—lung—esophageal cancer	0.000344	0.0103	CbGeAlD
Conjugated Estrogens—ABCC4—lung—esophageal cancer	0.000331	0.00991	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—esophageal cancer	0.000328	0.00984	CbGeAlD
Conjugated Estrogens—Ulcer—Capecitabine—esophageal cancer	0.000323	0.00467	CcSEcCtD
Conjugated Estrogens—Cyanosis—Methotrexate—esophageal cancer	0.000321	0.00465	CcSEcCtD
Conjugated Estrogens—Estrone—CYP1B1—esophageal cancer	0.000316	0.1	CrCbGaD
Conjugated Estrogens—Inflammation—Capecitabine—esophageal cancer	0.000315	0.00456	CcSEcCtD
Conjugated Estrogens—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000311	0.0045	CcSEcCtD
Conjugated Estrogens—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000307	0.00444	CcSEcCtD
Conjugated Estrogens—Pulmonary embolism—Capecitabine—esophageal cancer	0.000305	0.00442	CcSEcCtD
Conjugated Estrogens—Blood pressure increased—Capecitabine—esophageal cancer	0.000305	0.00442	CcSEcCtD
Conjugated Estrogens—ESR1—lung—esophageal cancer	0.000291	0.00874	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—esophageal cancer	0.000291	0.00872	CbGeAlD
Conjugated Estrogens—Fluid retention—Capecitabine—esophageal cancer	0.00029	0.0042	CcSEcCtD
Conjugated Estrogens—Necrosis—Methotrexate—esophageal cancer	0.00029	0.00419	CcSEcCtD
Conjugated Estrogens—Abscess—Methotrexate—esophageal cancer	0.000287	0.00416	CcSEcCtD
Conjugated Estrogens—Irritability—Cisplatin—esophageal cancer	0.000287	0.00416	CcSEcCtD
Conjugated Estrogens—Ethinyl Estradiol—ABCC2—esophageal cancer	0.000283	0.09	CrCbGaD
Conjugated Estrogens—ABCC1—lung—esophageal cancer	0.000282	0.00845	CbGeAlD
Conjugated Estrogens—Blood creatinine increased—Cisplatin—esophageal cancer	0.000282	0.00408	CcSEcCtD
Conjugated Estrogens—Dehydration—Cisplatin—esophageal cancer	0.00028	0.00405	CcSEcCtD
Conjugated Estrogens—COMT—lymph node—esophageal cancer	0.000277	0.00832	CbGeAlD
Conjugated Estrogens—Neoplasm—Capecitabine—esophageal cancer	0.000276	0.004	CcSEcCtD
Conjugated Estrogens—ABCC3—lymph node—esophageal cancer	0.000274	0.00821	CbGeAlD
Conjugated Estrogens—Hypokalaemia—Cisplatin—esophageal cancer	0.000274	0.00396	CcSEcCtD
Conjugated Estrogens—Breast disorder—Cisplatin—esophageal cancer	0.000272	0.00393	CcSEcCtD
Conjugated Estrogens—Cramp muscle—Cisplatin—esophageal cancer	0.000271	0.00392	CcSEcCtD
Conjugated Estrogens—CYP1A2—digestive system—esophageal cancer	0.000269	0.00806	CbGeAlD
Conjugated Estrogens—Sepsis—Capecitabine—esophageal cancer	0.000265	0.00384	CcSEcCtD
Conjugated Estrogens—Extravasation—Methotrexate—esophageal cancer	0.000261	0.00377	CcSEcCtD
Conjugated Estrogens—Phlebitis—Capecitabine—esophageal cancer	0.000257	0.00373	CcSEcCtD
Conjugated Estrogens—Thrombophlebitis—Capecitabine—esophageal cancer	0.000256	0.00371	CcSEcCtD
Conjugated Estrogens—SLCO2B1—lymph node—esophageal cancer	0.000255	0.00766	CbGeAlD
Conjugated Estrogens—Pancreatitis—Cisplatin—esophageal cancer	0.000255	0.00369	CcSEcCtD
Conjugated Estrogens—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000254	0.00367	CcSEcCtD
Conjugated Estrogens—Sweating increased—Cisplatin—esophageal cancer	0.000253	0.00367	CcSEcCtD
Conjugated Estrogens—Bone disorder—Methotrexate—esophageal cancer	0.000252	0.00364	CcSEcCtD
Conjugated Estrogens—Swelling—Capecitabine—esophageal cancer	0.000251	0.00364	CcSEcCtD
Conjugated Estrogens—Abdominal discomfort—Cisplatin—esophageal cancer	0.000249	0.00361	CcSEcCtD
Conjugated Estrogens—Oliguria—Methotrexate—esophageal cancer	0.000247	0.00357	CcSEcCtD
Conjugated Estrogens—Ulcer—Methotrexate—esophageal cancer	0.00024	0.00348	CcSEcCtD
Conjugated Estrogens—Renal failure acute—Capecitabine—esophageal cancer	0.00024	0.00348	CcSEcCtD
Conjugated Estrogens—Estradiol—CYP1B1—esophageal cancer	0.000239	0.0762	CrCbGaD
Conjugated Estrogens—Inflammation—Methotrexate—esophageal cancer	0.000234	0.00339	CcSEcCtD
Conjugated Estrogens—ABCG2—lung—esophageal cancer	0.000233	0.007	CbGeAlD
Conjugated Estrogens—Renal impairment—Capecitabine—esophageal cancer	0.000233	0.00337	CcSEcCtD
Conjugated Estrogens—Dermatitis bullous—Capecitabine—esophageal cancer	0.000232	0.00336	CcSEcCtD
Conjugated Estrogens—Purpura—Capecitabine—esophageal cancer	0.00023	0.00333	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000228	0.00331	CcSEcCtD
Conjugated Estrogens—Renal failure—Cisplatin—esophageal cancer	0.000228	0.0033	CcSEcCtD
Conjugated Estrogens—Pulmonary embolism—Methotrexate—esophageal cancer	0.000227	0.00329	CcSEcCtD
Conjugated Estrogens—Vaginal inflammation—Methotrexate—esophageal cancer	0.000227	0.00329	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000227	0.00329	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Cisplatin—esophageal cancer	0.000227	0.00329	CcSEcCtD
Conjugated Estrogens—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000226	0.00328	CcSEcCtD
Conjugated Estrogens—ABCC4—lymph node—esophageal cancer	0.000226	0.00678	CbGeAlD
Conjugated Estrogens—CYP1A2—lung—esophageal cancer	0.000225	0.00673	CbGeAlD
Conjugated Estrogens—Cystitis noninfective—Methotrexate—esophageal cancer	0.000222	0.00321	CcSEcCtD
Conjugated Estrogens—Pain in extremity—Capecitabine—esophageal cancer	0.000222	0.00321	CcSEcCtD
Conjugated Estrogens—Cystitis—Methotrexate—esophageal cancer	0.00022	0.00318	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000219	0.00317	CcSEcCtD
Conjugated Estrogens—ABCC2—lymph node—esophageal cancer	0.000219	0.00656	CbGeAlD
Conjugated Estrogens—Migraine—Capecitabine—esophageal cancer	0.000218	0.00316	CcSEcCtD
Conjugated Estrogens—Vaginal infection—Methotrexate—esophageal cancer	0.000215	0.00311	CcSEcCtD
Conjugated Estrogens—Irritability—Capecitabine—esophageal cancer	0.000212	0.00306	CcSEcCtD
Conjugated Estrogens—Mood swings—Capecitabine—esophageal cancer	0.00021	0.00304	CcSEcCtD
Conjugated Estrogens—Blood creatinine increased—Capecitabine—esophageal cancer	0.000208	0.00301	CcSEcCtD
Conjugated Estrogens—Dehydration—Capecitabine—esophageal cancer	0.000206	0.00298	CcSEcCtD
Conjugated Estrogens—Neoplasm—Methotrexate—esophageal cancer	0.000206	0.00298	CcSEcCtD
Conjugated Estrogens—Bladder pain—Methotrexate—esophageal cancer	0.000206	0.00298	CcSEcCtD
Conjugated Estrogens—Hypokalaemia—Capecitabine—esophageal cancer	0.000202	0.00292	CcSEcCtD
Conjugated Estrogens—Visual impairment—Cisplatin—esophageal cancer	0.0002	0.0029	CcSEcCtD
Conjugated Estrogens—Breast disorder—Capecitabine—esophageal cancer	0.0002	0.0029	CcSEcCtD
Conjugated Estrogens—ESR1—lymph node—esophageal cancer	0.000199	0.00597	CbGeAlD
Conjugated Estrogens—Sepsis—Methotrexate—esophageal cancer	0.000197	0.00286	CcSEcCtD
Conjugated Estrogens—CYP3A4—digestive system—esophageal cancer	0.000195	0.00584	CbGeAlD
Conjugated Estrogens—Eye disorder—Cisplatin—esophageal cancer	0.000194	0.00281	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Cisplatin—esophageal cancer	0.000193	0.0028	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Capecitabine—esophageal cancer	0.000193	0.00279	CcSEcCtD
Conjugated Estrogens—ABCC1—lymph node—esophageal cancer	0.000193	0.00578	CbGeAlD
Conjugated Estrogens—Dysphagia—Capecitabine—esophageal cancer	0.000192	0.00277	CcSEcCtD
Conjugated Estrogens—Influenza—Capecitabine—esophageal cancer	0.000192	0.00277	CcSEcCtD
Conjugated Estrogens—Asthma—Capecitabine—esophageal cancer	0.000192	0.00277	CcSEcCtD
Conjugated Estrogens—Thrombophlebitis—Methotrexate—esophageal cancer	0.000191	0.00276	CcSEcCtD
Conjugated Estrogens—Estriol—ABCB1—esophageal cancer	0.00019	0.0606	CrCbGaD
Conjugated Estrogens—Bronchospasm—Capecitabine—esophageal cancer	0.000188	0.00273	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Cisplatin—esophageal cancer	0.000188	0.00272	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Cisplatin—esophageal cancer	0.000187	0.00271	CcSEcCtD
Conjugated Estrogens—Sweating increased—Capecitabine—esophageal cancer	0.000187	0.0027	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Cisplatin—esophageal cancer	0.000186	0.00269	CcSEcCtD
Conjugated Estrogens—Bronchitis—Capecitabine—esophageal cancer	0.000184	0.00267	CcSEcCtD
Conjugated Estrogens—Alopecia—Cisplatin—esophageal cancer	0.000184	0.00266	CcSEcCtD
Conjugated Estrogens—Abdominal discomfort—Capecitabine—esophageal cancer	0.000184	0.00266	CcSEcCtD
Conjugated Estrogens—ABCB1—epithelium—esophageal cancer	0.000181	0.00543	CbGeAlD
Conjugated Estrogens—Erythema—Cisplatin—esophageal cancer	0.000181	0.00262	CcSEcCtD
Conjugated Estrogens—Malnutrition—Cisplatin—esophageal cancer	0.000181	0.00262	CcSEcCtD
Conjugated Estrogens—Dysuria—Capecitabine—esophageal cancer	0.000179	0.00259	CcSEcCtD
Conjugated Estrogens—Renal failure acute—Methotrexate—esophageal cancer	0.000179	0.00259	CcSEcCtD
Conjugated Estrogens—Flatulence—Cisplatin—esophageal cancer	0.000178	0.00258	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000178	0.00258	CcSEcCtD
Conjugated Estrogens—Estramustine—ABCB1—esophageal cancer	0.000177	0.0563	CrCbGaD
Conjugated Estrogens—Weight increased—Capecitabine—esophageal cancer	0.000174	0.00252	CcSEcCtD
Conjugated Estrogens—Visual disturbance—Methotrexate—esophageal cancer	0.000174	0.00252	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Cisplatin—esophageal cancer	0.000174	0.00252	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Capecitabine—esophageal cancer	0.000173	0.0025	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Capecitabine—esophageal cancer	0.000171	0.00247	CcSEcCtD
Conjugated Estrogens—Infestation—Capecitabine—esophageal cancer	0.000171	0.00247	CcSEcCtD
Conjugated Estrogens—Vision blurred—Cisplatin—esophageal cancer	0.000171	0.00247	CcSEcCtD
Conjugated Estrogens—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000171	0.00247	CcSEcCtD
Conjugated Estrogens—Depression—Capecitabine—esophageal cancer	0.00017	0.00247	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000168	0.00244	CcSEcCtD
Conjugated Estrogens—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000168	0.00244	CcSEcCtD
Conjugated Estrogens—Renal failure—Capecitabine—esophageal cancer	0.000168	0.00243	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Capecitabine—esophageal cancer	0.000167	0.00242	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000167	0.00242	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000162	0.00234	CcSEcCtD
Conjugated Estrogens—ABCB1—trachea—esophageal cancer	0.00016	0.0048	CbGeAlD
Conjugated Estrogens—ABCG2—lymph node—esophageal cancer	0.00016	0.00479	CbGeAlD
Conjugated Estrogens—Irritability—Methotrexate—esophageal cancer	0.000158	0.00228	CcSEcCtD
Conjugated Estrogens—Convulsion—Cisplatin—esophageal cancer	0.000157	0.00227	CcSEcCtD
Conjugated Estrogens—Mood swings—Methotrexate—esophageal cancer	0.000156	0.00226	CcSEcCtD
Conjugated Estrogens—Myalgia—Cisplatin—esophageal cancer	0.000154	0.00223	CcSEcCtD
Conjugated Estrogens—Rhinitis—Capecitabine—esophageal cancer	0.000154	0.00223	CcSEcCtD
Conjugated Estrogens—Anxiety—Cisplatin—esophageal cancer	0.000154	0.00222	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000153	0.00222	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Capecitabine—esophageal cancer	0.000153	0.00221	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Capecitabine—esophageal cancer	0.000152	0.0022	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Capecitabine—esophageal cancer	0.000151	0.00219	CcSEcCtD
Conjugated Estrogens—Breast disorder—Methotrexate—esophageal cancer	0.000149	0.00216	CcSEcCtD
Conjugated Estrogens—Oedema—Cisplatin—esophageal cancer	0.000148	0.00214	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Cisplatin—esophageal cancer	0.000148	0.00214	CcSEcCtD
Conjugated Estrogens—Visual impairment—Capecitabine—esophageal cancer	0.000148	0.00214	CcSEcCtD
Conjugated Estrogens—Infection—Cisplatin—esophageal cancer	0.000147	0.00213	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Capecitabine—esophageal cancer	0.000145	0.0021	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Cisplatin—esophageal cancer	0.000145	0.0021	CcSEcCtD
Conjugated Estrogens—Tachycardia—Cisplatin—esophageal cancer	0.000144	0.00209	CcSEcCtD
Conjugated Estrogens—Skin disorder—Cisplatin—esophageal cancer	0.000144	0.00208	CcSEcCtD
Conjugated Estrogens—Eye disorder—Capecitabine—esophageal cancer	0.000143	0.00207	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Cisplatin—esophageal cancer	0.000143	0.00207	CcSEcCtD
Conjugated Estrogens—Asthma—Methotrexate—esophageal cancer	0.000143	0.00206	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Capecitabine—esophageal cancer	0.000142	0.00206	CcSEcCtD
Conjugated Estrogens—Anorexia—Cisplatin—esophageal cancer	0.000141	0.00204	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Methotrexate—esophageal cancer	0.00014	0.00202	CcSEcCtD
Conjugated Estrogens—Angiopathy—Capecitabine—esophageal cancer	0.000139	0.00201	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Capecitabine—esophageal cancer	0.000139	0.00201	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Capecitabine—esophageal cancer	0.000138	0.002	CcSEcCtD
Conjugated Estrogens—Hypotension—Cisplatin—esophageal cancer	0.000138	0.002	CcSEcCtD
Conjugated Estrogens—ABCB1—digestive system—esophageal cancer	0.000138	0.00413	CbGeAlD
Conjugated Estrogens—Arrhythmia—Capecitabine—esophageal cancer	0.000137	0.00198	CcSEcCtD
Conjugated Estrogens—Abdominal discomfort—Methotrexate—esophageal cancer	0.000137	0.00198	CcSEcCtD
Conjugated Estrogens—Alopecia—Capecitabine—esophageal cancer	0.000136	0.00196	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000135	0.00195	CcSEcCtD
Conjugated Estrogens—Mental disorder—Capecitabine—esophageal cancer	0.000134	0.00195	CcSEcCtD
Conjugated Estrogens—Malnutrition—Capecitabine—esophageal cancer	0.000133	0.00193	CcSEcCtD
Conjugated Estrogens—Erythema—Capecitabine—esophageal cancer	0.000133	0.00193	CcSEcCtD
Conjugated Estrogens—Dysuria—Methotrexate—esophageal cancer	0.000133	0.00193	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Cisplatin—esophageal cancer	0.000133	0.00192	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000133	0.00192	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Cisplatin—esophageal cancer	0.000132	0.00191	CcSEcCtD
Conjugated Estrogens—Flatulence—Capecitabine—esophageal cancer	0.000132	0.0019	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Capecitabine—esophageal cancer	0.000131	0.00189	CcSEcCtD
Conjugated Estrogens—Back pain—Capecitabine—esophageal cancer	0.000129	0.00187	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Cisplatin—esophageal cancer	0.000128	0.00186	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Capecitabine—esophageal cancer	0.000128	0.00186	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000128	0.00185	CcSEcCtD
Conjugated Estrogens—Infestation—Methotrexate—esophageal cancer	0.000127	0.00184	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Methotrexate—esophageal cancer	0.000127	0.00184	CcSEcCtD
Conjugated Estrogens—Depression—Methotrexate—esophageal cancer	0.000127	0.00184	CcSEcCtD
Conjugated Estrogens—Pain—Cisplatin—esophageal cancer	0.000126	0.00183	CcSEcCtD
Conjugated Estrogens—Vision blurred—Capecitabine—esophageal cancer	0.000126	0.00182	CcSEcCtD
Conjugated Estrogens—Renal failure—Methotrexate—esophageal cancer	0.000125	0.00181	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00012	0.00174	CcSEcCtD
Conjugated Estrogens—Vertigo—Capecitabine—esophageal cancer	0.00012	0.00174	CcSEcCtD
Conjugated Estrogens—Syncope—Capecitabine—esophageal cancer	0.00012	0.00173	CcSEcCtD
Conjugated Estrogens—Palpitations—Capecitabine—esophageal cancer	0.000118	0.00171	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Capecitabine—esophageal cancer	0.000117	0.0017	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—esophageal cancer	0.000117	0.00169	CcSEcCtD
Conjugated Estrogens—Cough—Capecitabine—esophageal cancer	0.000116	0.00169	CcSEcCtD
Conjugated Estrogens—ABCB1—lung—esophageal cancer	0.000115	0.00345	CbGeAlD
Conjugated Estrogens—Chest pain—Capecitabine—esophageal cancer	0.000114	0.00165	CcSEcCtD
Conjugated Estrogens—Arthralgia—Capecitabine—esophageal cancer	0.000114	0.00165	CcSEcCtD
Conjugated Estrogens—Myalgia—Capecitabine—esophageal cancer	0.000114	0.00165	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—esophageal cancer	0.000113	0.00164	CcSEcCtD
Conjugated Estrogens—Anxiety—Capecitabine—esophageal cancer	0.000113	0.00164	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000113	0.00163	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—esophageal cancer	0.00011	0.00159	CcSEcCtD
Conjugated Estrogens—Oedema—Capecitabine—esophageal cancer	0.000109	0.00158	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—esophageal cancer	0.000109	0.00158	CcSEcCtD
Conjugated Estrogens—Infection—Capecitabine—esophageal cancer	0.000108	0.00157	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—esophageal cancer	0.000108	0.00156	CcSEcCtD
Conjugated Estrogens—Shock—Capecitabine—esophageal cancer	0.000107	0.00155	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Capecitabine—esophageal cancer	0.000107	0.00155	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—esophageal cancer	0.000107	0.00154	CcSEcCtD
Conjugated Estrogens—Tachycardia—Capecitabine—esophageal cancer	0.000106	0.00154	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—esophageal cancer	0.000106	0.00154	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—esophageal cancer	0.000106	0.00153	CcSEcCtD
Conjugated Estrogens—Skin disorder—Capecitabine—esophageal cancer	0.000106	0.00153	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Capecitabine—esophageal cancer	0.000105	0.00152	CcSEcCtD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—esophageal cancer	0.000104	0.0331	CrCbGaD
Conjugated Estrogens—Anorexia—Capecitabine—esophageal cancer	0.000104	0.0015	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—esophageal cancer	0.000104	0.0015	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—esophageal cancer	0.000103	0.00149	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—esophageal cancer	0.000103	0.00149	CcSEcCtD
Conjugated Estrogens—Hypotension—Capecitabine—esophageal cancer	0.000102	0.00147	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—esophageal cancer	0.000101	0.00146	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—esophageal cancer	0.000101	0.00146	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—esophageal cancer	0.0001	0.00145	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—esophageal cancer	9.94e-05	0.00144	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—esophageal cancer	9.94e-05	0.00144	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Capecitabine—esophageal cancer	9.93e-05	0.00144	CcSEcCtD
Conjugated Estrogens—Insomnia—Capecitabine—esophageal cancer	9.85e-05	0.00143	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Capecitabine—esophageal cancer	9.78e-05	0.00142	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—esophageal cancer	9.73e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Capecitabine—esophageal cancer	9.71e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—esophageal cancer	9.61e-05	0.00139	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Capecitabine—esophageal cancer	9.59e-05	0.00139	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Capecitabine—esophageal cancer	9.47e-05	0.00137	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Capecitabine—esophageal cancer	9.41e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—esophageal cancer	9.4e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Fatigue—Capecitabine—esophageal cancer	9.39e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—esophageal cancer	9.37e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—esophageal cancer	9.32e-05	0.00135	CcSEcCtD
Conjugated Estrogens—Pain—Capecitabine—esophageal cancer	9.32e-05	0.00135	CcSEcCtD
Conjugated Estrogens—Constipation—Capecitabine—esophageal cancer	9.32e-05	0.00135	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—esophageal cancer	9.31e-05	0.00135	CcSEcCtD
Conjugated Estrogens—Estrone—ABCB1—esophageal cancer	9.06e-05	0.0288	CrCbGaD
Conjugated Estrogens—Vertigo—Methotrexate—esophageal cancer	8.93e-05	0.00129	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Capecitabine—esophageal cancer	8.91e-05	0.00129	CcSEcCtD
Conjugated Estrogens—Nausea—Cisplatin—esophageal cancer	8.78e-05	0.00127	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—esophageal cancer	8.67e-05	0.00126	CcSEcCtD
Conjugated Estrogens—Urticaria—Capecitabine—esophageal cancer	8.66e-05	0.00125	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Capecitabine—esophageal cancer	8.61e-05	0.00125	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Capecitabine—esophageal cancer	8.61e-05	0.00125	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—esophageal cancer	8.61e-05	0.00125	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—esophageal cancer	8.46e-05	0.00122	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—esophageal cancer	8.46e-05	0.00122	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—esophageal cancer	8.46e-05	0.00122	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	8.4e-05	0.00122	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—esophageal cancer	8.11e-05	0.00117	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—esophageal cancer	8.06e-05	0.00117	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Capecitabine—esophageal cancer	8.03e-05	0.00116	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—esophageal cancer	7.95e-05	0.00115	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—esophageal cancer	7.88e-05	0.00114	CcSEcCtD
Conjugated Estrogens—ABCB1—lymph node—esophageal cancer	7.87e-05	0.00236	CbGeAlD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—esophageal cancer	7.84e-05	0.00114	CcSEcCtD
Conjugated Estrogens—Asthenia—Capecitabine—esophageal cancer	7.82e-05	0.00113	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—esophageal cancer	7.73e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Pruritus—Capecitabine—esophageal cancer	7.71e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—esophageal cancer	7.58e-05	0.0011	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Capecitabine—esophageal cancer	7.45e-05	0.00108	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—esophageal cancer	7.39e-05	0.00107	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—esophageal cancer	7.34e-05	0.00106	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—esophageal cancer	7.28e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—esophageal cancer	7.23e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—esophageal cancer	7.21e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Dizziness—Capecitabine—esophageal cancer	7.2e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—esophageal cancer	7.14e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—esophageal cancer	7.05e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—esophageal cancer	7e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—esophageal cancer	6.99e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—esophageal cancer	6.94e-05	0.001	CcSEcCtD
Conjugated Estrogens—Vomiting—Capecitabine—esophageal cancer	6.93e-05	0.001	CcSEcCtD
Conjugated Estrogens—Rash—Capecitabine—esophageal cancer	6.87e-05	0.000995	CcSEcCtD
Conjugated Estrogens—Estradiol—ABCB1—esophageal cancer	6.87e-05	0.0219	CrCbGaD
Conjugated Estrogens—Dermatitis—Capecitabine—esophageal cancer	6.86e-05	0.000994	CcSEcCtD
Conjugated Estrogens—Headache—Capecitabine—esophageal cancer	6.83e-05	0.000988	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—esophageal cancer	6.63e-05	0.00096	CcSEcCtD
Conjugated Estrogens—Nausea—Capecitabine—esophageal cancer	6.47e-05	0.000937	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—esophageal cancer	6.44e-05	0.000933	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—esophageal cancer	6.41e-05	0.000928	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—esophageal cancer	6.41e-05	0.000928	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—esophageal cancer	5.98e-05	0.000865	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—esophageal cancer	5.82e-05	0.000843	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—esophageal cancer	5.74e-05	0.000831	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—esophageal cancer	5.55e-05	0.000803	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—esophageal cancer	5.36e-05	0.000777	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—esophageal cancer	5.16e-05	0.000747	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—esophageal cancer	5.11e-05	0.00074	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—esophageal cancer	5.11e-05	0.00074	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—esophageal cancer	5.08e-05	0.000736	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—esophageal cancer	4.82e-05	0.000698	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.67e-06	8.76e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ABCB1—esophageal cancer	8.6e-06	8.68e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ALDH2—esophageal cancer	8.57e-06	8.66e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PSME2—esophageal cancer	8.55e-06	8.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PSME1—esophageal cancer	8.55e-06	8.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	8.51e-06	8.6e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NOTCH2—esophageal cancer	8.37e-06	8.46e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.3e-06	8.39e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	8.29e-06	8.37e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BLVRB—esophageal cancer	8.28e-06	8.37e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC52A3—esophageal cancer	8.28e-06	8.37e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ENO1—esophageal cancer	8.25e-06	8.33e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS1—esophageal cancer	8.25e-06	8.33e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.24e-06	8.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PDE4D—esophageal cancer	8.22e-06	8.3e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—NOS3—esophageal cancer	8.21e-06	8.3e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	8.2e-06	8.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—EP300—esophageal cancer	8.19e-06	8.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTT1—esophageal cancer	8.15e-06	8.23e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PSME1—esophageal cancer	8.13e-06	8.21e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PSME2—esophageal cancer	8.13e-06	8.21e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—HMOX1—esophageal cancer	8.08e-06	8.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CA2—esophageal cancer	8.07e-06	8.15e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CYP2A6—esophageal cancer	8.06e-06	8.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.93e-06	8.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GNG7—esophageal cancer	7.81e-06	7.89e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ABCB1—esophageal cancer	7.76e-06	7.84e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	7.71e-06	7.79e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	7.69e-06	7.77e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TGFBR2—esophageal cancer	7.67e-06	7.75e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS1—esophageal cancer	7.64e-06	7.72e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ENO1—esophageal cancer	7.64e-06	7.72e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.63e-06	7.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PSME1—esophageal cancer	7.53e-06	7.6e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PSME2—esophageal cancer	7.53e-06	7.6e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTGS2—esophageal cancer	7.51e-06	7.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ADH7—esophageal cancer	7.5e-06	7.58e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PLCE1—esophageal cancer	7.5e-06	7.58e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.47e-06	7.55e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	7.44e-06	7.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.4e-06	7.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CYP1B1—esophageal cancer	7.38e-06	7.46e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—XIAP—esophageal cancer	7.32e-06	7.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SMAD4—esophageal cancer	7.26e-06	7.33e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.1e-06	7.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	7.08e-06	7.15e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC10A2—esophageal cancer	7.04e-06	7.11e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CA1—esophageal cancer	7.04e-06	7.11e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—HMOX1—esophageal cancer	7.04e-06	7.11e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CREBBP—esophageal cancer	7.03e-06	7.1e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—SMAD4—esophageal cancer	7.03e-06	7.1e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	7.01e-06	7.09e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CYP19A1—esophageal cancer	6.94e-06	7.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	6.92e-06	7e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.9e-06	6.97e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL2—esophageal cancer	6.88e-06	6.96e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ABCB1—esophageal cancer	6.75e-06	6.82e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	6.59e-06	6.66e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ADH1B—esophageal cancer	6.58e-06	6.64e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.5e-06	6.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CYP1B1—esophageal cancer	6.49e-06	6.56e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CA2—esophageal cancer	6.44e-06	6.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.43e-06	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PSME1—esophageal cancer	6.43e-06	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PSME2—esophageal cancer	6.43e-06	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ANXA1—esophageal cancer	6.4e-06	6.47e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.39e-06	6.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.39e-06	6.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—HMOX1—esophageal cancer	6.33e-06	6.4e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—NOS3—esophageal cancer	6.3e-06	6.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.29e-06	6.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMP—esophageal cancer	6.28e-06	6.35e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—EP300—esophageal cancer	6.25e-06	6.31e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SST—esophageal cancer	6.23e-06	6.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.21e-06	6.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	6.17e-06	6.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP26A1—esophageal cancer	6.11e-06	6.18e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CYP19A1—esophageal cancer	6.11e-06	6.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ABCB1—esophageal cancer	6.08e-06	6.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	6.07e-06	6.13e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GHRL—esophageal cancer	6.07e-06	6.13e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—PIK3CA—esophageal cancer	6.06e-06	6.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	6.03e-06	6.09e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—HMOX1—esophageal cancer	6.02e-06	6.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PLCE1—esophageal cancer	5.99e-06	6.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ADH7—esophageal cancer	5.99e-06	6.05e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FBXW7—esophageal cancer	5.97e-06	6.03e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALOX15—esophageal cancer	5.96e-06	6.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HIF1A—esophageal cancer	5.94e-06	6e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.92e-06	5.98e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.9e-06	5.96e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.86e-06	5.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—esophageal cancer	5.86e-06	5.92e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	5.79e-06	5.85e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ABCB1—esophageal cancer	5.78e-06	5.84e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTGS2—esophageal cancer	5.76e-06	5.82e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CREBBP—esophageal cancer	5.75e-06	5.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TPI1—esophageal cancer	5.68e-06	5.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTO1—esophageal cancer	5.68e-06	5.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—HMOX1—esophageal cancer	5.57e-06	5.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—esophageal cancer	5.53e-06	5.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALDOB—esophageal cancer	5.45e-06	5.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	5.44e-06	5.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CA1—esophageal cancer	5.43e-06	5.49e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.43e-06	5.49e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOS2—esophageal cancer	5.4e-06	5.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOTCH1—esophageal cancer	5.35e-06	5.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ABCB1—esophageal cancer	5.35e-06	5.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ADH1B—esophageal cancer	5.25e-06	5.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GAPDH—esophageal cancer	5.25e-06	5.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.24e-06	5.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CRABP1—esophageal cancer	5.2e-06	5.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CREBBP—esophageal cancer	5.18e-06	5.24e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NOTCH1—esophageal cancer	5.18e-06	5.23e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—NOS3—esophageal cancer	5.14e-06	5.2e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.11e-06	5.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	5.06e-06	5.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMP—esophageal cancer	5.02e-06	5.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CA2—esophageal cancer	4.97e-06	5.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNG7—esophageal cancer	4.94e-06	5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP26A1—esophageal cancer	4.88e-06	4.93e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CREBBP—esophageal cancer	4.85e-06	4.9e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	4.83e-06	4.88e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—EP300—esophageal cancer	4.79e-06	4.84e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALOX15—esophageal cancer	4.76e-06	4.8e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—esophageal cancer	4.71e-06	4.75e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—CREBBP—esophageal cancer	4.7e-06	4.75e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—NOS3—esophageal cancer	4.64e-06	4.69e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALDH2—esophageal cancer	4.63e-06	4.68e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PIK3CA—esophageal cancer	4.62e-06	4.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ADH7—esophageal cancer	4.62e-06	4.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.62e-06	4.67e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.6e-06	4.64e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SMAD4—esophageal cancer	4.57e-06	4.62e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTO1—esophageal cancer	4.54e-06	4.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TPI1—esophageal cancer	4.54e-06	4.58e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CREBBP—esophageal cancer	4.51e-06	4.56e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTT1—esophageal cancer	4.41e-06	4.45e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.37e-06	4.41e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2A6—esophageal cancer	4.36e-06	4.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALDOB—esophageal cancer	4.35e-06	4.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOS3—esophageal cancer	4.34e-06	4.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—esophageal cancer	4.25e-06	4.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GAPDH—esophageal cancer	4.19e-06	4.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CRABP1—esophageal cancer	4.15e-06	4.19e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS1—esophageal cancer	4.13e-06	4.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO1—esophageal cancer	4.13e-06	4.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.13e-06	4.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PSME1—esophageal cancer	4.07e-06	4.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PSME2—esophageal cancer	4.07e-06	4.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CREBBP—esophageal cancer	4.06e-06	4.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—esophageal cancer	4.06e-06	4.1e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.05e-06	4.09e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—NOS3—esophageal cancer	4.04e-06	4.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—esophageal cancer	3.97e-06	4.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNG7—esophageal cancer	3.95e-06	3.99e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—EP300—esophageal cancer	3.91e-06	3.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMP—esophageal cancer	3.87e-06	3.91e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CREBBP—esophageal cancer	3.86e-06	3.9e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.77e-06	3.81e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—esophageal cancer	3.74e-06	3.78e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.7e-06	3.74e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—esophageal cancer	3.7e-06	3.73e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.67e-06	3.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NOS3—esophageal cancer	3.64e-06	3.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—esophageal cancer	3.58e-06	3.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CREBBP—esophageal cancer	3.57e-06	3.61e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—esophageal cancer	3.54e-06	3.58e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—EP300—esophageal cancer	3.53e-06	3.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—esophageal cancer	3.52e-06	3.55e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.51e-06	3.55e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.5e-06	3.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TPI1—esophageal cancer	3.5e-06	3.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.48e-06	3.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—esophageal cancer	3.47e-06	3.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.46e-06	3.5e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NOS3—esophageal cancer	3.46e-06	3.49e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	3.37e-06	3.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.36e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—esophageal cancer	3.33e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EP300—esophageal cancer	3.3e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.3e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO1—esophageal cancer	3.3e-06	3.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.3e-06	3.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PSME1—esophageal cancer	3.25e-06	3.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PSME2—esophageal cancer	3.25e-06	3.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.23e-06	3.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.2e-06	3.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NOS3—esophageal cancer	3.2e-06	3.23e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—esophageal cancer	3.16e-06	3.19e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—EP300—esophageal cancer	3.07e-06	3.11e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CREBBP—esophageal cancer	3.05e-06	3.09e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNG7—esophageal cancer	3.05e-06	3.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HMOX1—esophageal cancer	3.01e-06	3.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—esophageal cancer	2.93e-06	2.96e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	2.89e-06	2.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—esophageal cancer	2.88e-06	2.91e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.85e-06	2.88e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.84e-06	2.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—esophageal cancer	2.82e-06	2.84e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.8e-06	2.83e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—esophageal cancer	2.79e-06	2.82e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—EP300—esophageal cancer	2.77e-06	2.79e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOS3—esophageal cancer	2.73e-06	2.76e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.72e-06	2.74e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.68e-06	2.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.64e-06	2.66e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—EP300—esophageal cancer	2.63e-06	2.66e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—esophageal cancer	2.61e-06	2.64e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—esophageal cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO1—esophageal cancer	2.54e-06	2.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.54e-06	2.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PSME2—esophageal cancer	2.51e-06	2.53e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PSME1—esophageal cancer	2.51e-06	2.53e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—esophageal cancer	2.44e-06	2.47e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—EP300—esophageal cancer	2.43e-06	2.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.4e-06	2.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.36e-06	2.38e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	2.27e-06	2.3e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—esophageal cancer	2.26e-06	2.28e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	2.19e-06	2.21e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.16e-06	2.19e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EP300—esophageal cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—esophageal cancer	2.05e-06	2.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.03e-06	2.05e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	1.94e-06	1.96e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CREBBP—esophageal cancer	1.93e-06	1.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.86e-06	1.88e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—esophageal cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.78e-06	1.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—esophageal cancer	1.77e-06	1.79e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NOS3—esophageal cancer	1.73e-06	1.75e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—esophageal cancer	1.58e-06	1.6e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.54e-06	1.56e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—esophageal cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NOS3—esophageal cancer	1.38e-06	1.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—EP300—esophageal cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NOS3—esophageal cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—EP300—esophageal cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—esophageal cancer	9.75e-07	9.85e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—esophageal cancer	9.74e-07	9.84e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—EP300—esophageal cancer	8.11e-07	8.19e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—esophageal cancer	7.77e-07	7.85e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6e-07	6.06e-06	CbGpPWpGaD
